Page last updated: 2024-08-24

triazoles and Cystic Fibrosis

triazoles has been researched along with Cystic Fibrosis in 53 studies

*Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. [MeSH]

Research

Studies (53)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (22.64)29.6817
2010's33 (62.26)24.3611
2020's8 (15.09)2.80

Authors

AuthorsStudies
Bentley, S; Davies, JC; Donovan, J; Gastine, S; Standing, JF1
Amaral, MD; Bacalhau, M; Buarque, CD; da Silva, VD; Ferreira, FC; Kmit, A; Lopes-Pacheco, M; Pimentel, AS; Souza, FR1
Brito Devoto, T; Cuestas, ML; Finquelievich, JL; García-Effrón, G; Hermida-Alva, K; Posse, G2
Balfour-Lynn, IM; Bentley, S; Carr, SB; Davies, JC1
Aller, SG; Bacsa, J; Breton, GW; Doiron, JE; Le, CA; Martin, KL; Turlington, M1
Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP1
Hanretty, AM; Langelier, C; Trang, TP; Yang, K1
Cases Viedma, E; García-Robles, AA; Jordá, C; Mancheño, N; Pemán, J; Poveda-Andrés, JL; Reig Mezquida, JP; Solé, A1
Armstrong-James, DPH; Eades, CP; Jones, A; Kelleher, P; Periselneris, J; Shah, A; Simmonds, N1
Kabulski, GM; MacVane, SH1
Abdolrasouli, A; Armstrong-James, D; Elborn, JS; Fisher, MC; Rhodes, J; Schelenz, S; Scourfield, A; Shah, A1
Armstrong-James, D; Nwankwo, L; Periselneris, J; Schelenz, S; Shah, A1
Claydon, A; Gaillard, EA; Modha, DE; Patel, D; Popple, S1
Baldelli, S; Cattaneo, D; Clementi, E; Colombo, C; Cozzi, V; Faelli, NML; Fusi, M; Russo, M1
Kirikou, H; Loukou, I; Moustaki, M; Petrocheilou, A; Stathi, A; Velegraki, A; Zachariadou, L1
Amin, A; Hussain, R; Johannesson, M; Oliynyk, I; Roomans, GM1
Chen, SC; Meyer, W; Middleton, PG1
Clements, RM; Estrada, L; Jon, CK; Mosquera, RA1
Moss, RB1
Clancy, CJ; Ensor, C; Joshi, R; Nguyen, MH; Shields, RK; Venkataramanan, R; Zhang, H; Zhao, W1
Augustynowicz-Kopeć, E; Garczewska, B; Jarzynka, S; Kuś, J; Skorupa, W1
Clifford, RL; Knox, AJ; Patel, JK; Poghosyan, A1
Barao Ocampo, M; Biffi, A; Colombo, C; De Lorenzis, G; Esposto, MC; Favuzzi, V; Koncan, R; Lo Cascio, G; Pizzamiglio, G; Prigitano, A; Romanò, L; Tortorano, AM1
Moreau-Marquis, S; O'Toole, GA; Stanton, BA1
Elnazir, B; Glackin, L; Greally, P; Leen, G1
Amrein, C; Batisse, A; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Dannaoui, E; Guillemain, R; Lillo-Le Louet, A; Loriot, MA; Pham, MH1
Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S1
Fothergill, AW; Hickey, PW; Rinaldi, MG; Schmidt, HJ; Sutton, DA; Walsh, TJ; Wickes, BL1
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A1
Bouchara, JP; Danner-Boucher, I; Despins, P; Gay-Andrieu, F; Haloun, A; Horeau-Langlard, D; Jossic, F; Le Pape, P; Miegeville, M; Morio, F; Nourry, L; Pattier, S; Talarmin, JP; Treilhaud, M1
Cooperstock, MS; Griffard, EA; Guajardo, JR; Scoville, CL1
Cheng, MP; Lands, LC; Ovetchkine, P; Paquette, K; Quach, C; Théoret, Y1
Cuthbert, AW1
Amrein, C; Beaune, PH; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Laurent-Puig, P; Le Beller, C; Lillo-Lelouet, A; Loriot, MA; Trégouet, DA1
Borghi, E; Iatta, R; Manca, A; Montagna, MT; Morace, G1
Garcia-Hermoso, D; Gay-Andrieu, F; Haloun, A; Le Pape, P; Leclair, F; Lepoivre, T; Miegeville, M; Miossec, C; Morio, F; Treilhaud, M1
Clifton, IJ; Conway, SP; Metcalfe, R; Peckham, DG; Phillip, M; Shaw, N; Whitaker, P1
Doudounakis, S; Katelari, A; Markantonis, SL; Pappa, E1
Bermudez, C; Bhama, JK; Clancy, CJ; Crespo, MM; Kwak, EJ; Mitsani, D; Nguyen, MH; Pilewski, JM; Shields, RK; Silveira, FP; Toyoda, Y1
Couderc, L; Dominique, S; Favennec, L; Leguillon, C; Marguet, C; Masseline, B; Pramil, S; Rondeau, S1
Aubin, GG; Bretagne, S; Danner-Boucher, I; Garcia-Hermoso, D; Haloun, A; Le Pape, P; Miegeville, M; Morio, F; Sacchetto, E1
Donald, MB; Kurth, MJ; Phuan, PW; Rodriguez, KX; Shay, H; Verkman, AS1
Balfour-Lynn, IM; Bentley, S; Gupta, A1
Buer, J; Dittmer, S; Hamprecht, A; Lackner, M; Rath, PM; Schemuth, H; Sedlacek, L; Steinmann, E; Steinmann, J1
Atalay, MA; Koç, N; Sav, H; Unal, E1
Brown, NE; Chow, L; Kunimoto, D1
Balfour-Lynn, I; Buchdahl, R; Bush, A; Davies, J; Edwards, S; Francis, J; Hilliard, T; Rosenthal, M1
Schoeni, MH1
Conte, JV; Dropulic, LK; Girgis, R; Mcdyer, JF; Orens, JB; Shlobin, OA; Yang, SY1
Denis, O; Estenne, M; Jacobs, F; Knoop, C; Nolard, N; Schrooyen, M; Symoens, F1
Alioua, D; Anract, P; Dougados, M; Dupont, B; Guerini, H; Guignard, S; Hubert, D; Paugam, A1
Diemert, D; Kunimoto, D; Rennie, R; Sand, C1

Reviews

3 review(s) available for triazoles and Cystic Fibrosis

ArticleYear
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
    Mycoses, 2021, Volume: 64, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Mycoses; Nitriles; Phylogeny; Pneumonia; Pyridines; Saccharomycetales; Triazoles

2021
Fungal infections and treatment in cystic fibrosis.
    Current opinion in pulmonary medicine, 2013, Volume: 19, Issue:6

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Candida; Candidiasis; Cystic Fibrosis; DNA, Fungal; Female; Humans; Itraconazole; Male; Pyrimidines; Scedosporium; Sputum; Triazoles; Vital Capacity; Voriconazole

2013
Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:2

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchiectasis; Cystic Fibrosis; Humans; Hypersensitivity; Immunoglobulin E; Triazoles

2015

Trials

2 trial(s) available for triazoles and Cystic Fibrosis

ArticleYear
Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10

    Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cystic Fibrosis; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole

2011
Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2012, Volume: 11, Issue:3

    Topics: Administration, Oral; Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Pyrimidines; Sunlight; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012

Other Studies

48 other study(ies) available for triazoles and Cystic Fibrosis

ArticleYear
Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 2021, 11-12, Volume: 76, Issue:12

    Topics: Adolescent; Child; Cystic Fibrosis; Drug Monitoring; Humans; Tablets; Triazoles

2021
Identification of novel F508del-CFTR traffic correctors among triazole derivatives.
    European journal of pharmacology, 2023, Jan-05, Volume: 938

    Topics: Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Mutation; Triazoles

2023
Antifungal susceptibility patterns for Aspergillus, Scedosporium, and Exophiala isolates recovered from cystic fibrosis patients against amphotericin B, and three triazoles and their impact after long-term therapies.
    Medical mycology, 2023, Aug-02, Volume: 61, Issue:8

    Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Azoles; Cystic Fibrosis; Exophiala; Itraconazole; Scedosporium; Triazoles; Voriconazole

2023
Combination antifungal therapy for Scedosporium species in cystic fibrosis.
    Pediatric pulmonology, 2020, Volume: 55, Issue:8

    Topics: Adolescent; Antifungal Agents; Ascomycota; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Mycoses; Retrospective Studies; Scedosporium; Terbinafine; Treatment Outcome; Triazoles

2020
Structural Consequences of the 1,2,3-Triazole as an Amide Bioisostere in Analogues of the Cystic Fibrosis Drugs VX-809 and VX-770.
    ChemMedChem, 2020, 09-16, Volume: 15, Issue:18

    Topics: Amides; Aminophenols; Aminopyridines; Benzodioxoles; Crystallography, X-Ray; Cystic Fibrosis; Humans; Models, Molecular; Molecular Structure; Quantum Theory; Quinolones; Triazoles

2020
High prevalence of triazole-resistant Aspergillus fumigatus sensu stricto in an Argentinean cohort of patients with cystic fibrosis.
    Mycoses, 2020, Volume: 63, Issue:9

    Topics: Adolescent; Adult; Antifungal Agents; Argentina; Aspergillosis; Aspergillus fumigatus; Child; Cystic Fibrosis; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Middle Aged; Mutation; Prevalence; Retrospective Studies; Sequence Analysis, DNA; Sputum; Triazoles; Young Adult

2020
Use of isavuconazole in a patient with voriconazole-induced QTc prolongation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:4

    Topics: Antifungal Agents; Cystic Fibrosis; Female; Humans; Long QT Syndrome; Lung Transplantation; Nitriles; Pyridines; Triazoles; Voriconazole; Young Adult

2017
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2018, Volume: 18, Issue:2

    Topics: Administration, Topical; Adult; Antifungal Agents; Cystic Fibrosis; Emphysema; Female; Humans; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Prognosis; Salvage Therapy; Scedosporium; Transplant Recipients; Triazoles

2018
Improvement in Exophiala dermatitidis airway persistence and respiratory decline in response to interferon-gamma therapy in a patient with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2018, Volume: 17, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Cystic Fibrosis; Disease Progression; Exophiala; Humans; Interferon-gamma; Interleukin-17; Lung Diseases, Fungal; Male; Monitoring, Immunologic; Nitriles; Pyridines; Recombinant Proteins; Respiratory Function Tests; Sputum; Treatment Outcome; Triazoles; Young Adult

2018
Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:3

    Topics: Adult; Antifungal Agents; Cystic Fibrosis; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Nitriles; Pyridines; Triazoles; Young Adult

2018
High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre.
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:5

    Topics: Adolescent; Adult; Age Distribution; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fungal Proteins; Hospitals; Humans; London; Male; Microbial Sensitivity Tests; Middle Aged; Polymorphism, Genetic; Prevalence; Prospective Studies; Real-Time Polymerase Chain Reaction; Triazoles; Young Adult

2018
Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 2019, 06-01, Volume: 74, Issue:6

    Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cystic Fibrosis; Disease Management; Humans; Immunoglobulin E; Retrospective Studies; Time Factors; Treatment Outcome; Triazoles; Young Adult

2019
Posaconazole therapy in children with cystic fibrosis and Aspergillus-related lung disease.
    Medical mycology, 2020, Jan-01, Volume: 58, Issue:1

    Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Child; Cystic Fibrosis; Female; Humans; Lung; Male; Prospective Studies; Triazoles

2020
Unexpected analytical interference in isavuconazole UV determination in a child in therapy with lumacaftor/ivacaftor for cystic fibrosis.
    Clinical chemistry and laboratory medicine, 2019, Oct-25, Volume: 57, Issue:11

    Topics: Aminophenols; Aminopyridines; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Benzodioxoles; Cystic Fibrosis; Female; Humans; Male; Nitriles; Pyridines; Quinolones; Triazoles

2019
Isolation of
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019, Volume: 24, Issue:29

    Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Cystic Fibrosis; Greece; Humans; Microbial Sensitivity Tests; Mycological Typing Techniques; Phylogeny; Sequence Analysis, DNA; Species Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sputum; Treatment Outcome; Triazoles; Young Adult

2019
The effect of NO-donors on chloride efflux, intracellular Ca(2+) concentration and mRNA expression of CFTR and ENaC in cystic fibrosis airway epithelial cells.
    Experimental and molecular pathology, 2013, Volume: 94, Issue:3

    Topics: Bronchi; Calcium; Cell Line; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Epithelial Sodium Channels; Gene Expression Regulation; Nitric Oxide Donors; RNA, Messenger; Triazoles

2013
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
    BMJ case reports, 2013, Nov-18, Volume: 2013

    Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole

2013
Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Cystic Fibrosis; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Male; Middle Aged; Triazoles

2016
Fungal infection of cystic fibrosis patients - single center experience.
    Pneumonologia i alergologia polska, 2016, Volume: 84, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Cystic Fibrosis; Drug Resistance, Multiple, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Scedosporium; Triazoles; Voriconazole; Yeasts

2016
Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelial cells.
    Biochemical and biophysical research communications, 2016, 08-05, Volume: 476, Issue:4

    Topics: Azepines; CCAAT-Enhancer-Binding Protein-beta; Cell Cycle Proteins; Cells, Cultured; Cystic Fibrosis; DNA Methylation; Epigenesis, Genetic; Epithelial Cells; Humans; Interleukin-1beta; Interleukin-8; Mutation; NF-kappa B; Nuclear Proteins; Promoter Regions, Genetic; Transcription Factor AP-1; Transcription Factors; Triazoles

2016
Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2017, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillus fumigatus; Child; Cystic Fibrosis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Environment; Female; Fungal Proteins; Humans; Italy; Male; Microbial Sensitivity Tests; Point Mutation; Prevalence; Pulmonary Aspergillosis; Triazoles

2017
Tobramycin and FDA-approved iron chelators eliminate Pseudomonas aeruginosa biofilms on cystic fibrosis cells.
    American journal of respiratory cell and molecular biology, 2009, Volume: 41, Issue:3

    Topics: Anti-Bacterial Agents; Benzoates; Biofilms; Cells, Cultured; Conalbumin; Cystic Fibrosis; Deferasirox; Deferoxamine; Epithelial Cells; Humans; Iron Chelating Agents; Pseudomonas Infections; Tobramycin; Triazoles; United States; United States Food and Drug Administration

2009
Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Irish medical journal, 2009, Volume: 102, Issue:1

    Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Confidence Intervals; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Immunoglobulin E; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole

2009
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cystic Fibrosis; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Mycoses; Pyrimidines; Scedosporium; Tacrolimus; Triazoles; Voriconazole; Young Adult

2009
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
    Therapeutic drug monitoring, 2009, Volume: 31, Issue:3

    Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole

2009
Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis.
    Journal of clinical microbiology, 2009, Volume: 47, Issue:10

    Topics: Amphotericin B; Antifungal Agents; Cystic Fibrosis; Echinocandins; Fatal Outcome; Humans; Lung; Lung Diseases, Fungal; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Mycoses; Radiography, Thoracic; Retrospective Studies; Triazoles; Trichosporon

2009
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Journal of clinical pharmacy and therapeutics, 2010, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2010
Disseminated Scedosporium/Pseudallescheria infection after double-lung transplantation in patients with cystic fibrosis.
    Journal of clinical microbiology, 2010, Volume: 48, Issue:5

    Topics: Adult; Antifungal Agents; Brain; Caspofungin; Chemoprevention; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Female; Humans; Lipopeptides; Lung Diseases, Fungal; Lung Transplantation; Magnetic Resonance Imaging; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Naphthalenes; Pseudallescheria; Pyrimidines; Radiography; RNA, Fungal; RNA, Ribosomal, 28S; Scedosporium; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole

2010
Isolation of Exophiala dermatitidis from pigmented sputum in a cystic fibrosis patient.
    Pediatric pulmonology, 2010, Volume: 45, Issue:5

    Topics: Adolescent; Adrenal Cortex Hormones; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Humans; Lung Diseases, Fungal; Mycoses; Pyrimidines; Recurrence; Sputum; Triazoles; Voriconazole

2010
Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Pediatric pulmonology, 2010, Volume: 45, Issue:7

    Topics: Adolescent; Antifungal Agents; Child; Cohort Studies; Cystic Fibrosis; Dietary Supplements; Female; Humans; Male; Photosensitivity Disorders; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Vision Disorders; Vitamin A; Voriconazole

2010
Lubiprostone targets prostanoid EP₄ receptors in ovine airways.
    British journal of pharmacology, 2011, Volume: 162, Issue:2

    Topics: Adenylyl Cyclases; Alprostadil; Animals; Chloride Channels; CLC-2 Chloride Channels; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Humans; Lubiprostone; Molecular Targeted Therapy; Receptors, Prostaglandin E, EP4 Subtype; Respiratory Mucosa; Sheep; Thiophenes; Trachea; Triazoles

2011
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.
    European journal of clinical pharmacology, 2011, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Cystic Fibrosis; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Lung Transplantation; Male; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis.
    Medical mycology, 2010, Volume: 48 Suppl 1

    Topics: Adult; Antifungal Agents; Cystic Fibrosis; Fatal Outcome; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Random Amplified Polymorphic DNA Technique; Scedosporium; Triazoles; Voriconazole

2010
Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.
    Journal of clinical microbiology, 2011, Volume: 49, Issue:7

    Topics: Adult; Antifungal Agents; Ascomycota; Caspofungin; Cystic Fibrosis; DNA, Fungal; Echinocandins; Fatal Outcome; Fungemia; Heart Transplantation; Histocytochemistry; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Male; Microscopy; Molecular Sequence Data; Mycoses; Pleura; Pyrimidines; Radiography, Thoracic; Sequence Analysis, DNA; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Central Nervous System; Chromatography, High Pressure Liquid; Cystic Fibrosis; Drug Monitoring; Female; Fungi; Humans; Liver; Lung; Lung Transplantation; Male; Middle Aged; Mycoses; Prospective Studies; Pulmonary Fibrosis; Pyrimidines; Treatment Outcome; Triazoles; United States; Voriconazole

2012
High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
    The European respiratory journal, 2012, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Dermatitis, Phototoxic; Female; Humans; Male; Pyrimidines; Severity of Illness Index; Triazoles; Voriconazole; Young Adult

2012
High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8

    Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Fungal; France; Humans; In Vitro Techniques; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyrimidines; Retrospective Studies; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole; Young Adult

2012
Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis.
    Bioorganic & medicinal chemistry, 2012, Sep-01, Volume: 20, Issue:17

    Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Molecular Structure; Structure-Activity Relationship; Thiazoles; Triazoles

2012
Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2013, Volume: 12, Issue:4

    Topics: Adolescent; Antifungal Agents; Child; Cystic Fibrosis; Humans; Itraconazole; Prospective Studies; Pyrimidines; Triazoles; Voriconazole

2013
In vitro activity of colistin as single agent and in combination with antifungals against filamentous fungi occurring in patients with cystic fibrosis.
    Mycoses, 2013, Volume: 56, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Caspofungin; Colistin; Cystic Fibrosis; Drug Evaluation, Preclinical; Drug Synergism; Echinocandins; Exophiala; Humans; Lipopeptides; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2013
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4

    Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Nov-01, Volume: 35, Issue:9

    Topics: Adult; Antifungal Agents; Aspergillosis; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2002
Voriconazole therapy in children with cystic fibrosis.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2005, Volume: 4, Issue:4

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Retrospective Studies; Sputum; Statistics, Nonparametric; Treatment Outcome; Triazoles; Voriconazole

2005
To treat or not to treat with antifungal agents?
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2005, Volume: 4, Issue:4

    Topics: Adolescent; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases, Fungal; Male; Pyrimidines; Sputum; Triazoles; Voriconazole

2005
Mediastinal mass due to Aspergillus fumigatus after lung transplantation: a case report.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:11

    Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Fatal Outcome; Female; Humans; Immunocompromised Host; Lipopeptides; Lung Transplantation; Magnetic Resonance Imaging; Mediastinal Diseases; Peptides, Cyclic; Postoperative Complications; Pyrimidines; Recurrence; Thoracoscopy; Triazoles; Voriconazole

2005
Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:5

    Topics: Adult; Antifungal Agents; Bronchi; Chorioretinitis; Cystic Fibrosis; Fatal Outcome; Female; Humans; Immunocompromised Host; Lung Transplantation; Meningitis, Fungal; Mycetoma; Pyrimidines; Scedosporium; Sputum; Triazoles; Voriconazole

2006
Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2008, Volume: 7, Issue:1

    Topics: Adult; Antifungal Agents; Caspofungin; Cystic Fibrosis; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Male; Mycetoma; Pleurisy; Pyrimidines; Scedosporium; Spondylitis; Thoracic Vertebrae; Triazoles; Voriconazole

2008
Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:10

    Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Exophiala; Female; Hemoptysis; Humans; Lung Diseases, Fungal; Magnetic Resonance Imaging; Pyrimidines; Sputum; Triazoles; Voriconazole

2001